KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $11.2 million.

  • Evolent Health's Other Non-Current Assets fell 1547.38% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 1547.38%. This contributed to the annual value of $13.4 million for FY2024, which is 1037.95% up from last year.
  • Evolent Health's Other Non-Current Assets amounted to $11.2 million in Q3 2025, which was down 1547.38% from $12.5 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Other Non-Current Assets ranged from a high of $32.6 million in Q4 2021 and a low of $11.2 million during Q3 2025
  • Moreover, its 5-year median value for Other Non-Current Assets was $14.6 million (2023), whereas its average is $17.8 million.
  • Per our database at Business Quant, Evolent Health's Other Non-Current Assets tumbled by 4647.81% in 2022 and then surged by 1037.95% in 2024.
  • Evolent Health's Other Non-Current Assets (Quarter) stood at $32.6 million in 2021, then plummeted by 46.48% to $17.5 million in 2022, then plummeted by 30.59% to $12.1 million in 2023, then rose by 10.38% to $13.4 million in 2024, then fell by 16.58% to $11.2 million in 2025.
  • Its Other Non-Current Assets stands at $11.2 million for Q3 2025, versus $12.5 million for Q2 2025 and $13.3 million for Q1 2025.